GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » Cash Flow for Lease Financing

Biohit Oyj (OHEL:BIOBV) Cash Flow for Lease Financing : €-0.27 Mil (TTM As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj Cash Flow for Lease Financing?

Biohit Oyj's Cash Flow for Lease Financing for the six months ended in Dec. 2023 was €-0.17 Mil. Biohit Oyj's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.27 Mil.

Compared with last quarter (€-0.10 Mil in Jun. 2023 ), Biohit Oyj's Cash Flow for Lease Financing remained the same in Dec. 2023 (€-0.17 Mil).

Biohit Oyj Cash Flow for Lease Financing Historical Data

The historical data trend for Biohit Oyj's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj Cash Flow for Lease Financing Chart

Biohit Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.22 -0.22 -0.27 -0.19 -0.27

Biohit Oyj Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 - - -0.10 -0.17

Biohit Oyj Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biohit Oyj Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Biohit Oyj (OHEL:BIOBV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » Cash Flow for Lease Financing
Comparable Companies
OHEL:HRTIS OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX INCY KRTX SRPT
Traded in Other Exchanges
N/A
Address
Laippatie 1, Helsinki, FIN, 00880
Website
https://www.biohithealthcare.com
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines